Kindling-associated SV2A expression in hilar GABAergic interneurons of the mouse dentate gyrus. 2012

Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
Laboratory of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. yohno@gly.oups.ac.jp

Immunohistochemical studies were performed to analyze the expressional changes in hippocampal synaptic vesicle protein 2A (SV2A) following pentylenetetrazole (PTZ) kindling. Repeated treatments of mice with sub-convulsive PTZ (40 mg/kg, i.p.) for 15 days progressively enhanced seizure susceptibility and induced clonic convulsions in most animals examined. Topographical analysis of hippocampal SV2A-immunoreactivity revealed that SV2A was densely expressed in the hilar region of the dentate gyrus, stratum lucidum of the CA3 field and around the periphery of CA3 pyramidal neurons. PTZ kindling region-specifically increased SV2A expression in the dentate hilus without affecting that in the stratum lucidum or the pyramidal cell layer of the CA3 field. Confocal laser microscopic analysis using PTZ-kindled mice illustrated that most SV2A was co-expressed with glutamic acid decarboxylase 67 in the cell bodies and dendrites of hilar interneurons. However, SV2A-immunoreactivity was negligibly observed in the hilar glutamatergic nerve terminals (mossy fibers) probed with the anti-vesicular glutamate transporter 1 antibody. The present study suggests that SV2A specifically regulates hilar GABAergic neurotransmission in the kindled hippocampus probably as a compensatory or prophylactic mechanism against kindling epileptogenesis.

UI MeSH Term Description Entries
D007395 Interneurons Most generally any NEURONS which are not motor or sensory. Interneurons may also refer to neurons whose AXONS remain within a particular brain region in contrast to projection neurons, which have axons projecting to other brain regions. Intercalated Neurons,Intercalated Neuron,Interneuron,Neuron, Intercalated,Neurons, Intercalated
D007696 Kindling, Neurologic The repeated weak excitation of brain structures, that progressively increases sensitivity to the same stimulation. Over time, this can lower the threshold required to trigger seizures. Kindlings, Neurologic,Neurologic Kindling,Neurologic Kindlings
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050598 Vesicular Glutamate Transport Protein 1 A vesicular glutamate transporter protein that is predominately expressed in TELENCEPHALON of the BRAIN. Vesicular Glutamate Transporter 1,BNPI Protein,Brain-Specific Na-Dependent Inorganic Phosphate Cotransporter,VGLUT1 Protein,Brain Specific Na Dependent Inorganic Phosphate Cotransporter

Related Publications

Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
April 2013, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
January 1992, The European journal of neuroscience,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
January 2016, The Behavioral and brain sciences,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
October 1991, Brain research,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
July 2008, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
December 2007, Brain research,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
February 2024, Molecular neurobiology,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
January 2022, PloS one,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
January 2019, eNeuro,
Yukihiro Ohno, and Takahiro Okumura, and Ryo Terada, and Shizuka Ishihara, and Tadao Serikawa, and Masashi Sasa
May 1998, Neuroscience letters,
Copied contents to your clipboard!